BMAL1 and adrenal cortex carcinoma: Furthermore, SW-13 cell, the adrenocortical carcinoma (ACC), depleted BMAL1 increases the sensitivity to Zeocin, and that overexpression of BMAL1-WT, but not BMAL1-S183A, increases the resistance of SW-13 cell to Zeocin (Supplementary Fig. 6c–f).